Skip to main content
Figure 3 | Arthritis Research & Therapy

Figure 3

From: B cell depletion in diffuse progressive systemic sclerosis: safety, skin score modification and IL-6 modulation in an up to thirty-six months follow-up open-label trial

Figure 3

B and T cell staining in systemic sclerosis biopsies. In a forearm biopsy, immunohistochemistry revealed an expression of the B-cell marker CD20 in a limited number of (a) lymphocytes while a prominent expression of the T-cell marker CD3 was detected in the (b) perivascular lymphocytic infiltrate. Original magnification × 400.

Back to article page